Navigation Links
VCU study shows hormone-like molecule kills cells that cause inflammation in allergic disease

bone marrow.

In the in vitro portion of the study, researchers used mouse bone marrow cells containing the stem cells that give rise to mast cells. They cultured these precursor cells in conditions that allow mast cells to develop, and then added IFNγ to some of these cultures. A high rate of cell death yielding no living mast cells was observed in the cultures that received IFNγ.

Similar results were reported in vivo using a mouse model. Mice with a mutation that causes them to overproduce IFNγ were used, and again, researchers observed a significant decrease in mast cell numbers due to the excess of IFNγ. When researchers tried to culture mast cells from the bone marrow of these mice, the mast cells died.

Furthermore, a separate strain of mice with the same mutation as the first strain, but that had also been engineered to prevent IFNγ production, were found to have almost as many mast cells as normal mice, if not more. They concluded that the presence of high IFNγ levels blocked mast cell development.


'"/>

Source:Virginia Commonwealth University


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
(Date:10/10/2008)..., MARSHFIELD, MILWAUKEE, MADISON Governor Jim D...een four Wisconsin research institutions to advanc...that proactively addresses diseases. The Wisconsin...ffort among the Marshfield Clinic, Medical College...l of Medicine and Public Health (UWSMPH) and UW-Mi...
(Date:10/10/2008)... New Haven, Conn. Yale scientists have created n... electronics that are both sensitive and specific ...detection, according to a report in Nano Letters ...y highly specific antigens signatures of bacteria... cells are activated, they produce acid, and gener...
(Date:10/9/2008)... Convenient online registration to the IOF World ...ed rates, is available only until October 31, 2008...ration, please visit http://www.iofbonehealth.org...es are available for participants from non-OECD co...8 only on-site registration, at higher rates, will...
(Date:10/9/2008)... , Will climate change exceed life,s ability to r...in the Oct. 10, 2008 issue of the journal, Scienc...ostered by the Smithsonian Tropical Research Insti... , As an extremely diverse region of rainforest a...ose as a result of global warming. Some disagree, ...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2Sensitive nanowire disease detectors made by Yale scientists 2Smithsonian perspective: Biodiversity in a warmer world 2Dartmouth researchers advance cellulosic ethanol production 7558 1Dartmouth researchers advance cellulosic ethanol production 7558 2Carbon molecule with a charge could be tomorrows semiconductor 7557 1Carbon molecule with a charge could be tomorrows semiconductor 7557 2Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 1Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 2Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 3Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 4Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 1Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 2Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 3
...ditions early in the year mean that 2006 is shapin...s in almost four decades, according to Art Shapiro..., That,s a turnaround from last spring, when milli...he Central Valley. But other species have seen ste...om the region altogether. , "It has been the wors...
...ies that mimic the way insects, plants and animals...ur dependence on energy, according to new research... , When faced with engineering difficulties, such ... up to 70 per cent of man-made technologies manipu...order to resolve the problem. , However, new rese...
...ucted by Delft University of Technology has brough...friendly fuel bio-ethanol a great deal closer to f... was an important factor in this. His research in ...f certain sugars from agricultural waste to ethano...ee for his research into the subject. , The searc...
...lth & Science University study is adding crede...is what bonds stem cells with bone marrow cells to... School of Medicine found that transplanted cells ...tinal stem cells of both normal and diseased tissu...ls, known as the epithelium. The findings, reporte...
Other Biology News:Where have all the butterflies gone? 2Copying nature could save us energy, study shows 2Producing bio-ethanol from agricultural waste a step closer 2OHSU study says stem cell 'fusion' occurs in tumors 2OHSU study says stem cell 'fusion' occurs in tumors 3
(Date:10/10/2008)...ss., Oct. 10 /- Boston Scie...t has received approval from the,U.S. Food and Dru...tion,TAXUS(R) Liberte(R) Paclitaxel-Eluting Corona...AXUS Liberte stent early next month in the United,...f its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel-E...
(Date:10/10/2008)...iangsu, CHINA, Oct. 10 /Xinhua-- Beik...ch.com ) a global leader in,stem cell research an...nced,today it has signed eight separate mutual coo...ld,s most outstanding stem cell research organizat...tablished a "Stem Cell Expert,Advisory Committee" ...
(Date:10/10/2008)..., Del., Oct. 10 /- AstraZen... and Drug Administration (FDA) has,approved once-d...-Release,Tablets for the acute treatment of the de..., the manic and mixed episodes associated with bip...bipolar I disorder as adjunctive,therapy to lithiu...
(Date:10/10/2008)... Md., Oct. 10 /- EntreMed, ...cal company developing,therapeutics for the treatm... today that Thomas H. Bliss, Jr., EntreMed,s Senio...nt, will present a Company,overview at the 16th An...ng,held October 12-14, 2008 in London, United King...
Breaking Biology Technology:Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3
...ditor,s note: John Wade, VP/CIO, Saint Luke,s Heal...r at the annual Digital Healthcare Conference Ma...om his Kansas City office and offered a candid ass...ogy. , , WTN : What are the key remaining barrier..., , John Wade Wade: I think there are a couple...
...itor,s note: This is Part II of a three-part seri...Part I outlined the challenge facing businesses, a...n companies can do - and are doing - to address th...he estimates are accurate, about 10 percent of all... this year, and then the IT labor shortage will ki...
...When I last left you, it was in the middle of a we...ssion to open up a new trade office in that countr...both New and Old), the ancient capitol of Agra (ho...oved on to Mumbai (Bombay) for the last part of th...ons and key activities that the trade mission perf...
...Judy Lemke Green Bay, Wis. - Whenever the title..., the technologist usually is an established part ...ured out of retirement by Schneider National fol... , ,Lemke, executive vice president and CIO for th...n, logistics, and intermodal services, was recruit...
Other Biology Technology:Visions: Wade offers straight talk on e-medical records 2Visions: Wade offers straight talk on e-medical records 3Visions: Wade offers straight talk on e-medical records 4Visions: Wade offers straight talk on e-medical records 5IT workforce development: A little workforce planning goes a long way 2IT workforce development: A little workforce planning goes a long way 3IT workforce development: A little workforce planning goes a long way 4IT workforce development: A little workforce planning goes a long way 5A Midwest passage to India, Part II 2A Midwest passage to India, Part II 3A Midwest passage to India, Part II 4A Midwest passage to India, Part II 5A Midwest passage to India, Part II 6A Midwest passage to India, Part II 7A Midwest passage to India, Part II 8CIO Leadership Series: Judy Lemke, Schneider National 2CIO Leadership Series: Judy Lemke, Schneider National 3CIO Leadership Series: Judy Lemke, Schneider National 4CIO Leadership Series: Judy Lemke, Schneider National 5
Request Info
R26.4C
Chicken polyclonal to Opsin 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: YEDSTHASIFTYT, corresponding to amino acids 14/26 of Mouse Green cones Opsin 1; and synthetic
...W x H): 17 3/4" x 8 15/16" x 5 5/16"18.7 lbsCapa...trol: Programmable 30 - 99C Automated denaturation...ocols 3 operating modes (Denaturation/Hybridizatio...d temperature ramp-up from 37 - 95C and cooling fr...
Biology Products: